<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05075941</url>
  </required_header>
  <id_info>
    <org_study_id>2021-A01960-41</org_study_id>
    <nct_id>NCT05075941</nct_id>
  </id_info>
  <brief_title>Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations</brief_title>
  <acronym>PREVAC</acronym>
  <official_title>PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Epicentre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SANTE PUBLIQUE FRANCE</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medecins Sans Frontieres, Netherlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Médecins du Monde</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CROIX ROUGE FRANCAISE</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>OBSERVATOIRE DU SAMU SOCIAL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>INTERLOGEMENT 93</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Agence Regionale de Sante d'Ile de France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Epicentre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to assess the level of vaccination coverage (VC) against&#xD;
      COVID-19 among migrants, homeless and travelling community, according to their living&#xD;
      conditions and housing.&#xD;
&#xD;
      The secondary objectives are :&#xD;
&#xD;
        -  to compare the estimated level of vaccination coverage in the different sites and strata&#xD;
           (emergency shelters/hotels, camps, workers' hostels, on the street) with the estimated&#xD;
           level in the general population of the same territory obtained from the French Health&#xD;
           Insurance data (SIVAC).&#xD;
&#xD;
        -  identify the obstacles and leverage of vaccination (i.e. mobile team) according to&#xD;
           living conditions and habitat (socio-demographic factors, personal health history,&#xD;
           vaccine adherence, local health policies, etc.).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vaccination coverage among COVID-19</measure>
    <time_frame>one month</time_frame>
    <description>Assess the proportion of people declaring to have received at least one dose of vaccination against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify the most appropriate conditions for the use of vaccination against COVID-19</measure>
    <time_frame>one month</time_frame>
    <description>Promote interventions to encourage the use of COVID-19 vaccination</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">3470</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Shelters Paris/93</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Workers' hostels Paris/93</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>travelling community IDF(77/93/95)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Street/Camps Paris/93</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid Homeless and migrants Marseille</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hostel Paris/93</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vaccination coverage</intervention_name>
    <description>proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population</description>
    <arm_group_label>Covid Homeless and migrants Marseille</arm_group_label>
    <arm_group_label>Hostel Paris/93</arm_group_label>
    <arm_group_label>Shelters Paris/93</arm_group_label>
    <arm_group_label>Street/Camps Paris/93</arm_group_label>
    <arm_group_label>Workers' hostels Paris/93</arm_group_label>
    <arm_group_label>travelling community IDF(77/93/95)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        migrants, homeless and travelling community&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult (18 years and older)&#xD;
&#xD;
          -  People considered as homeless (homeless, living in a camp or squat) or&#xD;
&#xD;
          -  Living in adapted housing (migrant workers' hostel) or&#xD;
&#xD;
          -  Housed in residences of the National System or&#xD;
&#xD;
          -  Housed in a social residence such as a 115 hotel or a social housing centre&#xD;
&#xD;
          -  Freely and voluntarily consenting to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate in the study (non-consent).&#xD;
&#xD;
          -  Language barrier with no in-person or telephone translation available.&#xD;
&#xD;
          -  Impossibility to give free and informed consent (comprehension barrier, cognitive&#xD;
             and/or psychiatric and/or addictive disorders, external pressure from family and&#xD;
             friends, persons under guardianship, etc.).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Elisabeth POULET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Epicentre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas ROEDERER</last_name>
    <phone>+33 1 40 21 55 55</phone>
    <email>thomas.roederer@epicentre.msf.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica SAYYAD</last_name>
    <phone>+33 1 40 21 55 55</phone>
    <email>jessica.sayyad@epicentre.msf.org</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 7, 2021</study_first_submitted>
  <study_first_submitted_qc>October 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 13, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vaccination coverage</keyword>
  <keyword>migrants</keyword>
  <keyword>homeless</keyword>
  <keyword>travelling community</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The results will be presented in a report to the Ministry of Health, the Haute Autorité de Santé and the various partners. The main findings of this study could potentially be compared with the findings of other ongoing studies, once they are completed. An abstract of the findings will be submitted for presentation at a scientific conference, and at least one manuscript will be submitted for publication in a peer-reviewed scientific journal.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_access_criteria>Study partners</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

